David Pass
Chief Operating Officer at GELESIS INC
Net worth: 319 $ as of 30/12/2023
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yishai Zohar | M | 61 |
Gelesis Srl
 Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | 18 years |
| Clayton Christopher | M | 51 | 2 years | |
| Hassan M. Heshmati | M | 72 | 15 years | |
| Cosimo Saponaro | M | - |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | - |
| Alison Bauerlein | F | 42 | 2 years | |
| William Hait | M | 74 | 17 years | |
| Katie Sullivan | F | - | 4 years | |
| Kathryn Cavanaugh | F | 50 | 2 years | |
| Stephen M. Muniz | M | - |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | - |
| Jennifer Taubert | F | 60 | 19 years | |
| Giovanni Abbate | M | - |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | - |
| Angelo Tremblay | M | - | - | |
| Elizabeth Forminard | F | 53 | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul R. Fonteyne | M | 62 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 13 years |
| Elliot Maltz | M | 39 | 8 years | |
| David Abraham | M | 58 | 5 years | |
| Dominic Anthony Charles Perks | M | 47 | 2 years | |
| Desiree Ralls-Morrison | F | 57 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 12 years |
| James T. Lenehan | M | 75 | 28 years | |
| Marla Persky | F | 68 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 8 years |
| Jane Wildman | F | 63 | 2 years | |
| Raju S. Kucherlapati | M | 81 | 7 years | |
| John Johnson | M | 66 | 19 years | |
| J. Carroll | M | 74 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 years |
| Joseph Truitt | M | 59 | 4 years | |
| Hemanshu Shah | M | 63 | 1 years | |
| Christopher DelOrefice | M | 52 | 8 years | |
| Lisa Romanko | F | - | 19 years | |
| Wendy Hufford | F | 62 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 3 years |
| Sarah L. Colamarino | F | - | 13 years | |
| Carla Sivak | F | - | 4 years | |
| Curtis Selquist | M | 79 | 36 years | |
| Elaine Chiquette | M | 58 | 6 years | |
| Harry Leider | M | 66 | 4 years | |
| Christophe Soulier | M | - | 5 years | |
| John LaMattina | M | 74 | 9 years | |
| Charles O. Prince | M | 74 | 17 years | |
| William Perez | M | 76 | 13 years | |
| Michael Johns | M | 82 | 9 years | |
| Mary Coleman | M | 80 | 13 years | |
| Alessandro Sannino | M | 52 | 15 years | |
| Evan Norton | M | 49 | 3 years | |
| Wolfram Carius | M | 63 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | - |
| Susan L. Lindquist | M | 74 | - | |
| Robert J. Darretta | M | 78 | 39 years | |
| Jennifer Randall | F | - | - | |
| Vanessa Broadhurst | F | 55 | 16 years | |
| Gregory Lee | M | 61 | 5 years | |
| Robert Bazemore | M | 56 | 2 years | |
| Joseph Blechl | M | - | 2 years | |
| Adam Hacker | M | 55 | 10 years | |
| Denice Torres | F | 64 | 12 years | |
| Craig Buchholz | M | - | 3 years | |
| Janis Smith-Gomez | F | 57 | 16 years | |
| Richard C. Woodman | M | 69 | 4 years | |
| Duncan Fatkin | M | - | 11 years | |
| Elizabeth Hanna | F | 59 | 8 years | |
| Suneel Gupta | M | 66 | 6 years | |
| Lisa Shapiro Strovink | F | - | 1 years | |
| Sandy Pound | F | - | 14 years | |
| Kim Rodriguez | F | - | 2 years | |
| Roberto di Bernardini | M | 60 | 9 years | |
| An Phan | F | 49 | - | |
| Yves Decadt | M | 57 | 5 years | |
| Raymond C. Jordan | M | 70 | 9 years | |
| Michael C. Chen | M | 74 | 9 years | |
| John A. Salvagno | M | - | 3 years | |
| Robert A. Medv | M | 58 | 5 years | |
| Gérard Vaillant | M | 82 | 17 years | |
| Robert Kenneth Lally | M | 68 | 4 years | |
| Peter Pfreundschuh | M | 55 | 8 years | |
| Gerard N. Burrow | M | - | 12 years | |
| M. Judah Folkman | M | - | 7 years | |
| Ann Dibble Jordan | F | 89 | 26 years | |
| Henry B. Schacht | M | 89 | 8 years | |
| Maxine Frank Singer | M | - | 12 years | |
| Robert Wilson | M | 83 | 39 years | |
| Per A. Peterson | M | 79 | 13 years | |
| Jack B. Wilkens | M | - | 2 years | |
| Raymond Andrews | M | 70 |
Bristol-Myers Squibb Pharma Co.
| 4 years |
| Tony Vernon | M | 69 | 23 years | |
| Ronit Bendori | M | - | 6 years | |
| Cameron Durrant | M | 63 | 2 years | |
| Julie McHugh | F | 59 | 2 years | |
| Helen E. Short | F | 74 | - | |
| William McComb | M | 61 | 14 years | |
| Louise Mehrotra | F | - | 11 years | |
| Jerry Chang | M | 65 | 8 years | |
| Rob Jones | M | - | 7 years | |
| Mark R. Straley | M | 63 | - | |
| John Tagliamonte | M | 57 | 3 years | |
| Gerald Ostrov | M | 73 | 15 years | |
| Sean Cao | M | - | 3 years | |
| Anil Kapur | M | 54 | 11 years | |
| Frank Stonebanks | M | - | 6 years | |
| Pierre B. Pirard | M | 56 | 15 years | |
| Ken Berlin | M | 59 | 13 years | |
| Christopher J. Stergion | M | 58 | 15 years | |
| Patrick J. O'Neill | M | 74 | 30 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.98% |
| Italy | 4 | 4.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Pass
- Personal Network